Cardioprotective properties of fibrates: which fibrate, which patients, what mechanism?
- PMID: 16567579
- DOI: 10.1161/CIRCULATIONAHA.105.620450
Cardioprotective properties of fibrates: which fibrate, which patients, what mechanism?
Comment on
-
Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.Circulation. 2006 Mar 28;113(12):1556-63. doi: 10.1161/CIRCULATIONAHA.105.565135. Epub 2006 Mar 13. Circulation. 2006. PMID: 16534013 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
